A Digital Publication for the Practicing Medical Specialist, Industry Executive & Investor

4WEB Medical Announces FDA 510(k) Clearance of Stand-Alone Anterior Lumbar Interbody Fusion Device

Company Expands its Anterior Spine Truss System with the Addition of Integrated Fixation

4WEB Medical, an orthopedic device company focused on developing innovative implants with an Advanced Structural Design that utilizes its proprietary Truss Implant Technology™, announced today that the company has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its Stand-Alone Anterior Lumbar Interbody Fusion Device (ASTS-SA).

The new design allows fixation screws to be placed through the truss implant and into the adjacent vertebral bodies creating a zero-profile stand-alone construct that removes the need for supplemental fixation. Additionally, the device features single-step locking mechanisms that provide surgeon users confidence in the performance of the stand-alone construct. The anterior lumbar stand-alone product line will be available in multiple footprints, lordotic angles, and heights. The product line will be delivered in sterile packaging for hospital efficiency and patient safety.

“We are excited to add another spine interbody implant to our Truss Implant Technology™ portfolio,” said Jim Bruty, Sr. Vice President of Sales and Marketing. “The addition of the Stand-Alone Anterior Spine Truss System not only broadens our current offering, but we anticipate this launch to provide significant growth to the organization for the remainder of 2020. 4WEB will continue to stay focused on investments in product development, clinical research, and procedural-based solutions as a means to achieving our long-term growth strategy.”

Consistent with 4WEB’s existing product portfolio, ASTS-SA has an Advanced Structural Design that incorporates the company’s proprietary Truss Implant Technology™. Under normal loading conditions, the struts in the truss implant transfer strain to adjacent cellular material which stimulates a mechanobiologic response.

This is the second 510(k) clearance 4WEB Medical has received in 2020. The company has additional plans to launch a stand-alone lateral lumbar implant later this year.

Medical Device News Magazinehttps://infomeddnews.com
Medical Device News Magazine provides breaking medical device / biotechnology news. Our subscribers include medical specialists, device industry executives, investors, and other allied health professionals, as well as patients who are interested in researching various medical devices. We hope you find value in our easy-to-read publication and its overall objectives! Medical Device News Magazine is a division of PTM Healthcare Marketing, Inc. Pauline T. Mayer is the managing editor.

More News!

The Evolut ™ FX+ TAVR system leverages market-leading valve performance with addition of larger windows to facilitate coronary access
The study was an analysis of AstraZeneca’s Phase 2 52-Week clinical trial of tralokinumab in patients with Idiopathic Pulmonary Fibrosis (IPF). The patient data from the trial was processed with Brainomix’s e-Lung tool. The tool is uniquely powered by the weighted reticulovascular score (WRVS), a novel biomarker that incorporates reticular opacities and vascular structures of the lung.
“Since the algorithm for matching patients with donors is changing across for all organs, this was a prime time to better understand whether transplant team decisions to accept a donated organ varied by patient race and gender,” she said. “We wanted to understand how the process of receiving a transplant after listing varied by race and gender, and the combination of the two, so that steps can be taken to make that process more equitable," said Khadijah Breathett, MD.
The Mount Sinai study found that primary care physicians’ approach reflects a dearth of evidence-based guidance for lung cancer screening shared decision-making in patients with complex comorbidities
This is the first ever transplantation of a genetically engineered porcine kidney into a living human recipient.

By using this website you agree to accept Medical Device News Magazine Privacy Policy